a public good project by the
Synthesis
Company
of California

© 2026

Adam C. Stein | doi.page

0 works0 citations0 h-index

Adam C. Stein

Deoxi Biotecnologia (Brazil)(BR)Celldex Therapeutics (United States)(US)

Publications by Year

Research Areas

Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Gastrointestinal Bleeding Diagnosis and Treatment, Reproductive System and Pregnancy

Most-Cited Works

→ Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial(2016)199 cited
→ Brief report: Factors affecting outpatient follow-up compliance of emergency department patients(2005)122 cited
→ Nutritional considerations for a new era: A CF foundation position paper(2023)57 cited
→ Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial(2019)55 cited
→ Prevalence of Clostridium Difficile Colonization at Admission to Rehabilitation(2006)47 cited
→ Clinical predictors of bioterrorism-related inhalational anthrax(2004)44 cited

→ Obesity and Cardiovascular Risk in Adults With Celiac Disease(2015)

33 cited

→ Comparison of efficacy, pharmacokinetics, and immunogenicity between infliximab mono‐ versus combination therapy in ulcerative colitis(2014)32 cited

→ Vitamin A deficiency in the late gastrula stage rat embryo results in a one to two vertebral anteriorization that extends throughout the axial skeleton(2003)32 cited

→ 381 The AspireAssist Is an Effective Tool in the Treatment of Class II and Class III Obesity: Results of a One-Year Clinical Trial(2016)25 cited